Spanish pharma companies plan to continue extending their footprint around the world

Spanish pharmaceutical companies have developed a strong strategy in the last years to expand their products around the world, but these processes do not finish in selling drugs abroad, reports The Pharma Letter’s correspondent in Spain.

Also, almost every one of them has opened up new affiliates, commercial offices and production or R&D sites in other countries. In this sense, the favorite places were European countries, the USA or others regions, such as Latin America or Asia, for instance.

With regard to global presence, it is right to highlight Grifols (GRLS: MC), with 24 affiliates in Europe, North America, South America, Asia Pacific and Southeast Asia. Also, the Barcelona-based company has industrial facilities in the USA (Clayton, North Carolina; Melville, New York; and Los Angeles, California), Mexico (Guadalajara), Switzerland (Dudinguen), and Australia (Melbourne). People from the company declined to make statements about their plans for the future.